The Camperdown Program Outcomes of a New Prolonged-Speech Treatment Model Research Article
Research Article  |   August 01, 2003
The Camperdown Program
 
Author Affiliations & Notes
  • Sue O'Brian
    Australian Stuttering Research Centre, The University of Sydney Australia
  • Mark Onslow
    Australian Stuttering Research Centre, The University of Sydney Australia
  • Angela Cream
    Australian Stuttering Research Centre, The University of Sydney Australia
  • Ann Packman
    Australian Stuttering Research Centre, The University of Sydney Australia
  • Contact author: Sue O’Brian, Australian Stuttering Research Centre, The University of Sydney, East Street, Lidcombe NSW 2141, Australia. E-mail: s.obrian@fhs.usyd.edu.au
Article Information
Speech, Voice & Prosodic Disorders / Fluency Disorders / Speech, Voice & Prosody / Speech / Research Articles
Research Article   |   August 01, 2003
The Camperdown Program
Journal of Speech, Language, and Hearing Research, August 2003, Vol. 46, 933-946. doi:10.1044/1092-4388(2003/073)
History: Received June 4, 2002 , Accepted January 7, 2003
 
Journal of Speech, Language, and Hearing Research, August 2003, Vol. 46, 933-946. doi:10.1044/1092-4388(2003/073)
History: Received June 4, 2002; Accepted January 7, 2003
Web of Science® Times Cited: 80

Considerable research has been directed at the outcomes of prolonged-speech (PS) treatment for the control of chronic stuttering, but little research to date has focused on the PS treatment process. This report examines a Stage 2 clinical trial of a reconceptualized PS treatment model known as the Camperdown Program. This program requires fewer clinician hours than traditional programs and has no formal transfer phase. Additionally, it incorporates the following treatment process innovations, which replace treatment process components that are intuitively and empirically problematic: (a) PS is taught without incorporating target behaviors in clinician instruction, (b) participants learn to control stuttering without programmed instruction, and (c) the treatment process does not involve clinician identification of stuttering moments. Thirty participants were initially enrolled in the trial. Final outcome data are presented for the 16 participants who completed all trial requirements, including 12 months posttreatment data collection. These 16 participants showed minimal or no stuttering in everyday speaking situations for up to 12 months after entering the maintenance program, with speech rates in the normal range. Speech naturalness and social validation data were also favorable. Although self-report data generally confirmed the speech data, the results were not as positive. The present outcomes were achieved in a mean of 20 hours of clinic attendance per participant, which is much fewer than the hours required by treatment programs reported recently that run intensively over 2–3 weeks. The promise of this Stage 2 clinical trial has led the authors to initiate a Stage 3 randomized controlled trial of the Camperdown Program.

Acknowledgments
Completion of this project was made possible with Project Grant 980028 from the National Health and Medical Research Council of Australia. The authors also wish to express their appreciation to Rosemary Manusu for her support with the conduct of the clinical trial and to the clients who participated in the study.
Order a Subscription
Pay Per View
Entire Journal of Speech, Language, and Hearing Research content & archive
24-hour access
This Article
24-hour access